Interdisciplinary collaboration
Access to the resources of Stanford University -- including the Schools of Engineering, Law, Business, Humanities & Sciences and Education
Excellence in Scientific Discovery
The Institute's comprehensive investigations extend from the earliest phase of basic discovery to the development of new cancer diagnostics, treatment protocols and prevention strategies
Research Programs
Basic, clinical and translational studies into the biology of cancer and the factors that contribute to its onset and growth.
Shared Resources
The most sophisticated technologies and research protocols are offered to SCI members through a number of core facilities.
Key Initiatives
Inter-disciplinary teams of collaborative investigators partner to foster discovery, application and translation of scientific knowledge.
Institute Membership
Scientists and physicians from a wide range of disciplines, all dedicated to reducing the burden of cancer.
Events & Seminars
Events and seminars allow cancer specialists to share knowledge and foster new collaborations.
Funding Opportunities
Internal and external sources of support for both established cancer research programs and promising new ideas.
News & Publications
Publications, press releases and news are shared with scientists, physicians, patients and friends of the Institute.
Training Opportunities
Education and professional development designed to train the next generation of cancer researchers and physicians.
Clinical Trial Support
The Cancer Clinical Trials Office provides regulatory and administrative services to SCI members conducting clinical trials.
National Cancer Institute Designation
In addition to providing grants and other support to cancer researchers at institutions around the country, the National Cancer Institute employs scientists who conduct basic, clinical, and population-based research, including the study of rare cancers and the translation of laboratory findings to the clinic.
News & Publications
-
Artandi to lead Stanford Cancer Institute
A cancer biologist, Artandi studies the role of telomerase in stem cells and cancer. He replaces outgoing director Beverly Mitchell.
-
‘Cascade’ testing identifies relatives at risk
An online effort coupled with lower costs significantly increased the proportion of cancer patients’ relatives who chose to undergo genetic testing for cancer-associated mutations in Stanford study.
-
Test predicts lymphoma therapy success
Changes in circulating tumor DNA levels quickly predict how patients with diffuse large B cell lymphoma are responding to therapy, according to a Stanford-led study. Currently, patients wait months for the results.
